Citigroup Inc Travere Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 57,601 shares of TVTX stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,601

Previous 44,953 28.14%

Holding current value

$1 Million

Previous $369,000 118.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.89 - $15.21 $99,792 - $192,376	12,648 Added 28.14%	57,601 $805,000
Q2 2024 Aug 12, 2024	SELL	$5.26 - $8.28 $2.43 Million - $3.83 Million	-462,080 Reduced 91.13%	44,953 $369,000
Q1 2024 May 10, 2024	BUY	$7.18 - $9.82 $2.12 Million - $2.9 Million	294,970 Added 139.1%	507,033 $3.91 Million
Q4 2023 Feb 09, 2024	SELL	$5.44 - $9.5 $659,915 - $1.15 Million	-121,308 Reduced 36.39%	212,063 $1.91 Million
Q3 2023 Nov 09, 2023	BUY	$7.64 - $17.25 $518,824 - $1.17 Million	67,909 Added 25.58%	333,371 $2.98 Million
Q2 2023 Aug 10, 2023	SELL	$15.3 - $22.61 $1.48 Million - $2.18 Million	-96,609 Reduced 26.68%	265,462 $4.08 Million
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $3.86 Million - $4.96 Million	216,863 Added 149.35%	362,071 $8.14 Million
Q4 2022 Feb 09, 2023	SELL	$18.47 - $26.14 $852,870 - $1.21 Million	-46,176 Reduced 24.13%	145,208 $3.05 Million
Q3 2022 Nov 10, 2022	BUY	$22.91 - $28.63 $1.25 Million - $1.56 Million	54,490 Added 39.8%	191,384 $4.72 Million
Q2 2022 Aug 10, 2022	BUY	$20.94 - $30.01 $2.24 Million - $3.21 Million	107,049 Added 358.68%	136,894 $3.32 Million
Q1 2022 May 12, 2022	SELL	$23.61 - $30.6 $2.7 Million - $3.5 Million	-114,539 Reduced 79.33%	29,845 $770,000
Q4 2021 Feb 10, 2022	SELL	$24.34 - $31.17 $2.23 Million - $2.85 Million	-91,443 Reduced 38.78%	144,384 $4.48 Million
Q3 2021 Nov 10, 2021	BUY	$12.98 - $25.03 $3.06 Million - $5.9 Million	235,827 New	235,827 $5.72 Million

Others Institutions Holding TVTX

# of Institutions

192

Shares Held

84.5M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account